ZA899417B - Method for imparting immunosuppression - Google Patents

Method for imparting immunosuppression

Info

Publication number
ZA899417B
ZA899417B ZA899417A ZA899417A ZA899417B ZA 899417 B ZA899417 B ZA 899417B ZA 899417 A ZA899417 A ZA 899417A ZA 899417 A ZA899417 A ZA 899417A ZA 899417 B ZA899417 B ZA 899417B
Authority
ZA
South Africa
Prior art keywords
immunosuppression
imparting
imparting immunosuppression
Prior art date
Application number
ZA899417A
Other languages
English (en)
Inventor
Stanford Mark Moran
Mark Moran Stanford
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of ZA899417B publication Critical patent/ZA899417B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA899417A 1988-12-09 1989-12-08 Method for imparting immunosuppression ZA899417B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28209688A 1988-12-09 1988-12-09

Publications (1)

Publication Number Publication Date
ZA899417B true ZA899417B (en) 1991-02-27

Family

ID=23080093

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA899417A ZA899417B (en) 1988-12-09 1989-12-08 Method for imparting immunosuppression

Country Status (6)

Country Link
EP (1) EP0372541A1 (ja)
JP (1) JPH03115228A (ja)
AU (1) AU4597489A (ja)
CA (1) CA2004886A1 (ja)
DK (1) DK620989A (ja)
ZA (1) ZA899417B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157052A (en) * 1990-12-27 1992-10-20 Monsanto Company Method for inhibiting ige production
US20020006901A1 (en) 1999-02-05 2002-01-17 Aldo T. Iacono Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
SI1436321T1 (sl) 2001-10-19 2006-12-31 Isotechnika Inc Sinteza analogov ciklosporina

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3705092A1 (de) * 1987-02-18 1988-09-01 Bayer Ag Arzneimittelformulierung

Also Published As

Publication number Publication date
DK620989A (da) 1990-06-10
EP0372541A1 (en) 1990-06-13
DK620989D0 (da) 1989-12-08
AU4597489A (en) 1990-06-14
CA2004886A1 (en) 1990-06-09
JPH03115228A (ja) 1991-05-16

Similar Documents

Publication Publication Date Title
GB8814705D0 (en) Method
EP0329165A3 (en) Engine-control apparatus
GB8900947D0 (en) Painting method
GB8822145D0 (en) Method
YU7189A (en) Process for obtaining 1-alkyl-5-nitroimidazole
ZA893388B (en) Method of effecting immunosuppression
GB8827847D0 (en) Method
YU85489A (en) Process for obtaining l-alanyn
GB8829942D0 (en) Method
HUT49567A (en) Process for concentrating urea-solution
ZA899417B (en) Method for imparting immunosuppression
GB8818117D0 (en) Assembly method & apparatus
EP0327273A3 (en) Dyeimage forming method
GB8814340D0 (en) Process
GB8824068D0 (en) Santising process
GB8824672D0 (en) Process
GB8828878D0 (en) Process
GB8816575D0 (en) Well backsurging apparatus & method
GB8810354D0 (en) Method
YU36489A (en) Process for obtaining polyestheralcohole
PL272739A2 (en) Method for manufacturing ethyl menthoxyacetate
GB9200682D0 (en) Noncorruptible read-writer method
GB8800312D0 (en) Process
BG47208A1 (en) Method for tymphanostomy
YU204889A (en) Process for obtaining dinytrotoluol